SPECPAIR
Live / Registered — Registered (as of 16 Jan 2024)
What this means for you
Registered since 16 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90615199
- Registration number
- 7279821
- Mark type
- Stylized text
- Filed
- 31 Mar 2021
- Published for opposition
- 21 Dec 2021
- Registered
- 16 Jan 2024
- Attorney of record
- Alice A. Kelly
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of antibodies; research and development in the field of antibody drugs; research and development of antibody drugs for the treatment of various diseases including cancer; technical research in the field of antibodies; technology research in the field of antibody research and development; conducting early evaluations in the field of new antibodies; technical research in the field of engineering
Owner
- Phanes Therapeutics, Inc., San Diego, CA, US
- Phanes Therapeutics, Inc., San Diego, CA, US
- Phanes Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 22 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 14 Dec 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Dec 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Nov 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Nov 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Nov 2023 — ASSIGNED TO LIE
- 16 Jun 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Apr 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 25 Apr 2023 — NON-FINAL ACTION E-MAILED
- 25 Apr 2023 — SU - NON-FINAL ACTION - WRITTEN
- 06 Apr 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Mar 2023 — USE AMENDMENT FILED